EDSA — Edesa Biotech Share News
0.000.00%
Last trade - 00:00Edesa Biotech Inc expected to post a loss of 34 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Uber, Warner Music, Viridian Therapeutics
U.S. STOCKS ON THE MOVE-Edesa Biotech, Cognyte, Zivo Bioscience, automakers
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:07 PM
U.S. STOCKS ON THE MOVE-Nike, Teladoc, crypto stocks, energy stocks
Edesa surges as safety panel approves COVID-19 treatment trial
Brief: Edesa Biotech Inc Announces Positive Phase 2 Data Of Its Monoclonal Antibody
U.S. STOCKS ON THE MOVE-Verastem, Tesla, Synlogic, U.S. banks
Edesa Biotech Inc expected to post a loss of 32 cents a share - Earnings Preview
Edesa Biotech Inc expected to post a loss of 32 cents a share - Earnings Preview
Edesa Biotech Inc reports results for the quarter ended in March - Earnings Summary
Brief: Edesa Biotech - Qtrly Loss Per Share Of $0.19
Edesa Biotech Inc expected to post a loss of 29 cents a share - Earnings Preview
Edesa Biotech Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Edesa Biotech Inc Entered Into An Exclusive License Agreement With Saul Yedgar
Brief: Edesa Biotech Inc - There Were No Revenues For Three Months Ended December 31, 2020 Compared To $0.11 Million
Edesa Biotech: Soars on nod to test drug as rescue therapy for severe COVID-19
Edesa Biotech: Up on FDA nod for study on potential COVID-19 drug
NASDAQ RESUMED AT 09:45 AM